Catalent Pharma Solutions Joins Pharma & Biopharma Outsourcing Association
The Pharma & Biopharma Outsourcing Association (PBOA) recently announced that Catalent Pharma Solutions has joined the PBOA as a Sustaining Member. Cornell Stamoran, Vice President, Corporate Strategy & Government Affairs at Catalent and Board Member at Catalent Applied Drug Delivery Institute, has been elected to the PBOA’s Board of Trustees, effective immediately.
“Catalent Pharma Solutions is one of the world’s largest development and supply partners in the global pharmaceutical industry, and we’re delighted to bring them into the Pharma & Biopharma Outsourcing Association,” said Gil Roth, President of the PBOA. “Cornell Stamoran’s extensive experience and strategic focus will be of great value to our Board as we advance our membership’s legislative, regulatory, and business interests.”
“The outsourcing of drug product manufacturing has expanded significantly since I came to the advanced delivery technologies side of the industry in 1992,” added Mr. Stamoran. “Today, outsourcing serves a critical role in ensuring consistent supply of prescription, OTC, and consumer health products to our customers, and ultimately to patients. As a result, it is more important than ever for us to advocate for our interests, both legislative and regulatory. I’m pleased to represent Catalent, and to work to advance the Association’s goals.”
“I am very pleased to have Cornell join the Board,” added Peter T. Bigelow, Chairman of the Board at PBOA. “He brings a wealth of experience from his years in the pharmaceutical industry and will help the PBOA set and achieve its strategic goals.”
Cornell Stamoran serves as Vice President, Corporate Strategy & Government Affairs at Catalent, Inc. Mr. Stamoran leads Catalent’s strategic planning and market intelligence efforts, as well as supporting its government affairs, investor relations, global M&A and technology innovation, and acquisition activities. He also serves as a founding Director of Catalent’s Applied Drug Delivery Institute. He has spent more than 25 years engaged with the healthcare industry, including 23 years in advanced drug and biologic delivery and outsourcing. He currently serves on the Editorial Advisory Board of Drug Development & Delivery magazine, on several industry conference advisory teams, and on the steering committee for the Healthcare Institute of New Jersey (HINJ).
The Pharma & Biopharma Outsourcing Association is a nonprofit trade association dedicated to advancing the regulatory, legislative, and general business interests of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). PBOA members provide the services that help the pharma and biopharma industry develop and manufacture drugs, biologics, vaccines, and other treatments safely and cost effectively. The association’s Founding Members include Afton Scientific, Coldstream Laboratories, Cook Pharmica, Halo Pharma, Hospira One 2 One, Jubilant HollisterStier, Metrics Contract Services, Patheon, Therapure Biopharma, and WellSpring Pharma Services. For more information about the PBOA, its members, and its mission, please visit www.pharma-bio.org.
Total Page Views: 1216
